Neuroblastoma: open trials in Sweden

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vastra Gotalandsregionen, Gothenburg

  Registry updated 2026-10-30

• NCT07334301

  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  Trial Treatment · Phase 1/2 · University of Birmingham

  Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen, Gothenburg · Astrid Lindgren Children´s Hospital, Karolinska University Hospital, Stockholm

  Registry updated 2026-01-12

• NCT04221035

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris

  Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen, Gothenburg · Region Oestergoetland, Linkoping · Skåne University Hospital (pediatric), Lund · Karolinska University Hospital, Stockholm · Norrlands University Hospital, Umeå · Uppsala University Hospital, Uppsala

  Registry updated 2025-06-26

• NCT04903899

  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Trial Treatment · Phase 2 · Jakob Stenman

  Karolinska University Hospital, Solna

  Registry updated 2025-02-11

All Neuroblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error